Meta menu:

From here, you can access the Emergencies page, Contact Us page, Accessibility Settings, Language Selection, and Search page.

Open Menu
© Charité | Wiebke Peitz

Press release


Effects of deep brain stimulation in patients with Parkinson’s disease

Back to Overview

You are here:

Improved effects on motor function and fewer side effects possible

Das menschliche Gehirn als eine dreidimensionale Computersimulation: Durch die implantierten Elektroden der Tiefen Hirnstimulation erhalten Wissenschaftler Einblicke in die neuronalen Funktionen der Basalganglien und deren Nervenbahnen (Strukturen und Fasern im orangefarbenen Kreis). Die Basalganglien sind Bereiche im Gehirn, die unter anderem für die Motorik zuständig sind. Copyright: Charité/Neumann.
3D computer simulation of the human brain: The implantation of DBS electrodes enables researchers to gain insights into the functional roles of both the basal ganglia and their associated nerve tracts (structures and nerve tracts inside the orange circle). Basal ganglia are areas of the brain that are involved in movement and motor control. Copyright: Neumann/Charité

Researchers from Charité – Universitätsmedizin Berlin have studied motor and cognitive effects of deep brain stimulation in patients with Parkinson’s disease. Their results show that the adverse cognitive effects of deep brain stimulation are linked to a different neural pathway than that responsible for the treatment’s desired motor effects. This finding will help optimize treatments for patients with Parkinson’s disease. Results from this research have been published in Brain*

Deep brain stimulation (DBS) is an effective treatment alternative for Parkinson’s disease patients with an inadequate response to drug treatments. DBS targets the subthalamic nucleus, which forms part of the diencephalon, a division of the forebrain. The subthalamic nucleus integrates information from different neurons and is primarily responsible for motor processes, but also plays an important role in cognitive processes, such as decision-making and response modulation.

Researchers from Charité’s Department of Neurology on Campus Charité Mitte have studied the effect of DBS on both cognitive and motor pathways. By combining behavioral experiments with brain mapping and computational modeling, the researchers were able to show that effects on motor function – such as improvements in motor control – are mediated by different neural pathways to those responsible for unwanted cognitive effects, such as premature actions in situations involving a decision-making process.

These findings enhance our understanding of the neuronal networks affected by Parkinson’s disease, deliver insights into the pathophysiology of Parkinson’s disease, and enable us to draw conclusions regarding the mechanism of action of DBS. “Only an improved understanding of the treatment’s mechanism of action will allow us to make deep brain stimulation more effective, thus enabling us to improve the quality of life of patients with Parkinson’s disease through a reduction in the side effects of treatment,” explains the study’s first author, Dr. Wolf-Julian Neumann, a researcher at the Department of Neurology.

As a next step, the researchers from the Movement Disorders Working Group are hoping to use measurements of neural activity to differentiate between disease-specific patterns of neural activity and patterns found in healthy individuals. “This will allow us to adapt brain stimulation treatments according to the needs of the individual patient and in real time. “It is an important step on the way to developing an intelligent, personalized and demand-adapted treatment,” says Working Group Leader Prof. Dr. Andrea A. Kühn of the Department of Neurology.

* Neumann WJ et al. Functional segregation of basal ganglia pathways in Parkinson's disease. Brain. 2018 Aug 6. doi: 10.1093/brain/awy206.



Dr. Wolf-Julian Neumann
Department of Neurology
Movement Disorders Working Group
Charité – Universitätsmedizin Berlin
t: +49 30 450 560 123

Back to Overview